Investigation of water‐insoluble hydrophobic polyethylenimines as RNAi vehicles in chronic myeloid leukemia therapy
- 8 May 2021
- journal article
- research article
- Published by Wiley in Journal of Biomedical Materials Research Part A
- Vol. 109 (11) , 2306-2321
Abstract
The discovery of RNA interference (RNAi) more than two decades ago opened avenues for avant‐garde cancer treatments that possess the ability to evade issues hampering current chemotherapeutic strategies, owing to its specific gene sequence‐driven mechanism of action. A potent short interfering RNA (siRNA) delivery vehicle designed to overcome physiological barriers is imperative for successful RNAi therapy. For this purpose, this study explored the characteristics and therapeutic efficacy of low‐molecular weight (MW) polyethylenimine (PEI) with high cholesterol substitution, yielding water‐insoluble polymers, in chronic myeloid leukemia (CML) K562 cells. A strong impact of cholesterol grafting on the physicochemical attributes of the resultant polymers and their corresponding complexes with siRNA was observed, with the siRNA binding capacity of polymers increasing and complex dissociation sensitivity decreasing with increase in cholesterol content of the polymers. The modified polymer complexes were significantly smaller in size and possessed higher cationic charge compared to the parent polymer. The interaction with anionic heparan sulfate preoteoglycans present on the cell surface was significant in cellular uptake of the complexes. The therapeutic efficacy of siRNA/polymer complexes was reflected in their ability to effectively silence the reporter green fluorescent protein gene and endogenous CML oncogene BCR‐ABL as well as significantly inhibit colony formation by K562 cells post BCR‐ABL silencing. The results of this study demonstrated beneficial effects of high levels of hydrophobic substitution on low MW PEI on their functional performance bestowing them the potential to be potent RNAi agents for CML therapy.Keywords
Funding Information
- Institute of Cancer Research
- Natural Sciences and Engineering Research Council of Canada
This publication has 79 references indexed in Scilit:
- Cancer cell exosomes depend on cell-surface heparan sulfate proteoglycans for their internalization and functional activityProceedings of the National Academy of Sciences of the United States of America, 2013
- Effective Non-Viral Delivery of siRNA to Acute Myeloid Leukemia Cells with Lipid-Substituted PolyethyleniminesPLOS ONE, 2012
- Nonviral Gene Delivery Vectors Use Syndecan-Dependent Transport Mechanisms in Filopodia To Reach the Cell SurfaceACS Nano, 2012
- Cell Membrane–associated Heparan Sulfate Is a Receptor for Prototype Foamy Virus in Human, Monkey, and Rodent CellsMolecular Therapy, 2012
- Cellular Uptake, Intracellular Trafficking, and Cytotoxicity of NanomaterialsSmall, 2011
- Recent Advances in Lipid Nanoparticle Formulations with Solid Matrix for Oral Drug DeliveryAAPS PharmSciTech, 2010
- The Use of Inhibitors to Study Endocytic Pathways of Gene Carriers: Optimization and PitfallsMolecular Therapy, 2010
- Discontinuation of imatinib therapy after achieving a molecular responseBlood, 2004
- Progress and problems with the use of viral vectors for gene therapyNature Reviews Genetics, 2003
- Mis-assembly of clathrin lattices on endosomes reveals a regulatory switch for coated pit formation.Journal of Cell Biology, 1993